Tag: ai
-
Your Journey with Astron Health: From Referral to Personalized Research Report
Watch the complete presentation above for a detailed look at how patient’s can get an Astron report. The executive summary below covers key points from our video “Your Journey with Astron Health: From Referral to Personalized Research Report”, presented by Dr Padman, Chief Medical Officer at Astron Health. Executive Summary Astron Health offers a streamlined,…
-
Astron: Your Research Partner for Personalized Cancer Care
Watch the complete presentation above for detailed insights into our personalized cancer care approach. The executive summary below covers key points from our video “Astron: Your Research Partner for Personalized Cancer Care”, presented by Ben Whately, Chief Executive Officer at Astron Health. Executive Summary Astron Health exists to solve a major challenge in cancer care:…
-
“Turning Data into Confidence”: A Clinician’s Reflection on a Patient’s Journey
Recently, Dale Atkinson, a patient who used Astron’s Extended Precision Oncology Research service, shared a detailed account of his cancer journey. His story captures two difficult realities: With Dale’s permission, I’d like to share his words directly, as they vividly illustrate the patient experience and show how Astron can ease the burden of research and…
-
More Than Standard Precision Oncology: Why Astron’s Approach is Different
Watch the complete presentation above for a detailed look on what makes Astron’s approach different to standard precision oncology processes. The executive summary below covers key points from our video “More Than Standard Precision Oncology: Why Astron’s Approach is Different”, presented by Dr Padman, Chief Medical Officer at Astron Health. Executive Summary Astron Health serves…
-
Why everyone is talking about Extended Precision Oncology
Did you know that standard precision oncology can currently target fewer than 7% of known cancer driver genes? While genomic testing has advanced rapidly, and can now identifying thousands of molecular irregularities within cancer cells1, the development of new precision oncology drugs has not kept pace. That leaves over 93% of these potential targets unexplored.…
-
Innovation vs. Misinformation: How Astron Health Balances Curiosity with Clinical Evidence to Address the Toughest Challenges in Cancer Biology
In an age where medical misinformation spreads faster than peer-reviewed research, trust in healthcare innovation is under siege. While skepticism toward unproven therapies is justified, it’s essential not to conflate scientific exploration with pseudoscience. At Astron Health, we aim to answer some of the most difficult questions in cancer biology—not with conjecture, but through clinical…
Astron Health Blog 